Skip to navigation Skip to content

Severe growth failure with primary insulin-like growth factor-1 deficiency (IGFD) program in Pharmaceutical Benefits Scheme (PBS) 012-22092336




Severe growth failure with primary IGFD restriction and item codes

Do not share this attachment externally. See Information Publication Scheme

https://ourblueprint.internal.dept.local/content/images/icon-hidden-attachment.png|A linked attachment is available for staff only (i.e. under IPS/FOI)PBS Severe growth failure with primary IGFD restriction and item codes

Contact details

PBS Complex Drugs Programs

Forms

Severe growth failure with primary insulin-like growth factor-1 deficiency - mecasermin - initial authority application form (PB336)

Severe growth failure with primary insulin-like growth factor-1 deficiency - mecasermin - continuing authority application form (PB337)

Services Australia website

Severe growth failure with primary insulin-like growth factor-1 deficiency

External website

PBS schedule for severe growth failure with primary insulin-like growth factor-1 deficiency